Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583996 · ClinicalTrials.gov registry record · NA
The SHUNT-V Study for Varices
A NA study, sponsored by HepQuant.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT03583996: Completed NA study, sponsored by HepQuant.
NCT03583996 is a NA study that has completed, run by HepQuant. The registered enrollment target is 306 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03583996, a NA study, has completed, sponsored by HepQuant.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the Disease Severity Index (DSI) from the HepQuant SHUNT Liver Diagnostic Kit (Test) for likelihood of large esophageal varices.
Primary Outcome
The primary objective of this study is to measure the subjects' liver function using DSI ≤18.3 for those that are not likely to have large esophageal varices.
Interventions
- COMBINATION_PRODUCT HepQuant SHUNT Liver Diagnostic Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2022-10-22 |
| Phase | NA |
What the finished NCT03583996 record still lists
NCT03583996 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which HepQuant SHUNT Liver Diagnostic Test is the first listed.
NCT03583996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03583996 about?
NCT03583996 is a clinical study titled "The SHUNT-V Study for Varices". The purpose of this study is to validate the Disease Severity Index (DSI) from the HepQuant SHUNT Liver Diagnostic Kit (Test) for likelihood of large esophageal varices.
What is the current status of trial NCT03583996?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2019-01-23. Estimated completion is 2022-10-22.
What interventions are being tested in trial NCT03583996?
The interventions under investigation include: HepQuant SHUNT Liver Diagnostic Test (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03583996?
This trial is sponsored by HepQuant, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03583996's enrollment target sits among peer trials
306 324th of 2000 higher than 1,674 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI